20 Mar 2024

Venky's (India) gains on starting commercial production of Veterinary Medicine Products at Satara unit

Venky'S (India) is currently trading at Rs. 1606.30, up by 24.65 points or 1.56% from its previous closing of Rs. 1581.65 on the BSE.

The scrip opened at Rs. 1612.10 and has touched a high and low of Rs. 1638.65 and Rs. 1586.30 respectively. So far 8128 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 2312.95 on 07-Aug-2023 and a 52 week low of Rs. 1420.10 on 29-Mar-2023.

Last one week high and low of the scrip stood at Rs. 1658.30 and Rs. 1575.80 respectively. The current market cap of the company is Rs. 2259.47 crore.

The promoters holding in the company stood at 56.11%, while Institutions and Non-Institutions held 1.19% and 42.70% respectively.

Venky's (India) has started commercial production of Veterinary Medicine Products under its Animal Health Product Segment at Village Kesurdi, Taluka Satara, Maharashtra. This project is to manufacture Veterinary Medicines Powders (600 Tonnes/Annum) and Veterinary Medicines Liquids (300 Kilolitres / Annum) to cater the growing demand from poultry industry.

Venky’s (India) was established in 1976, mainly to produce day-old layer and broiler chicks for the dense poultry markets of North India.